BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8762727)

  • 21. The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients.
    Juul A; Main K; Blum WF; Lindholm J; Ranke MB; Skakkebaek NE
    Clin Endocrinol (Oxf); 1994 Jul; 41(1):85-93. PubMed ID: 7519529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of pubertal status and glycemic control on the growth hormone-IGF-I axis in boys with insulin-dependent diabetes mellitus.
    Clark PA; Clarke WL; Pedadda S; Reiss A; Langlois C; Nieves-Rivera F; Rogol AD
    J Pediatr Endocrinol Metab; 1998; 11(3):427-35. PubMed ID: 11517959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased 24 h mean insulin-like growth factor binding protein-3 proteolytic activity in pubertal type 1 diabetic boys.
    Zachrisson I; Brismar K; Carlsson-Skwirut C; Dahlquist G; Wallensteen M; Bang P
    Growth Horm IGF Res; 2000 Dec; 10(6):324-31. PubMed ID: 11161963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reference values for insulin-like growth factor-binding protein-3 (IGFBP-3) and the ratio of insulin-like growth factor-I to IGFBP-3 throughout childhood and adolescence.
    Löfqvist C; Andersson E; Gelander L; Rosberg S; Hulthen L; Blum WF; Wikland KA
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1420-7. PubMed ID: 15598696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin treatment normalizes reduced free insulin-like growth factor-I concentrations in diabetic children.
    Bereket A; Lang CH; Blethen SL; Ng LC; Wilson TA
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):321-6. PubMed ID: 8949570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum concentrations of type I and III procollagen propeptides in healthy children and girls with central precocious puberty during treatment with gonadotropin-releasing hormone analog and cyproterone acetate.
    Hertel NT; Stoltenberg M; Juul A; Main KM; Müller J; Nielsen CT; Lorenzen I; Skakkebaek NE
    J Clin Endocrinol Metab; 1993 Apr; 76(4):924-7. PubMed ID: 8473407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin-like growth factor I and insulin-like growth factor-binding proteins in bovine serum and follicular fluid before and after the preovulatory surge of luteinizing hormone.
    Funston RN; Seidel GE; Klindt J; Roberts AJ
    Biol Reprod; 1996 Dec; 55(6):1390-6. PubMed ID: 8949898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the components of insulin-like growth factor (IGF)-IGF binding protein (IGFBP) system in adolescents with type 1 diabetes and persistent microalbuminuria: relationship with increased urinary excretion of IGFBP-3 18 kD N-terminal fragment.
    Spagnoli A; Chiarelli F; Vorwerk P; Boscherini B; Rosenfeld RG
    Clin Endocrinol (Oxf); 1999 Nov; 51(5):587-96. PubMed ID: 10594519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Normative data for insulin-like growth factors (IGFs), IGF-binding proteins, and growth hormone-binding protein in a healthy Spanish pediatric population: age- and sex-related changes.
    Argente J; Barrios V; Pozo J; Muñoz MT; Hervás F; Stene M; Hernández M
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1522-8. PubMed ID: 7505288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increase in free insulin-like growth factor-I levels in precocious and normal puberty.
    Yamada M; Hasegawa T; Hasegawa Y
    Endocr J; 1998 Jun; 45(3):407-12. PubMed ID: 9790277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Free insulin-like growth factor I serum levels in 1430 healthy children and adults, and its diagnostic value in patients suspected of growth hormone deficiency.
    Juul A; Holm K; Kastrup KW; Pedersen SA; Michaelsen KF; Scheike T; Rasmussen S; Müller J; Skakkebaek NE
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2497-502. PubMed ID: 9253324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum prostate specific antigen, sex hormone binding globulin and free androgen index as markers of pubertal development in boys.
    Kim MR; Gupta MK; Travers SH; Rogers DG; Van Lente F; Faiman C
    Clin Endocrinol (Oxf); 1999 Feb; 50(2):203-10. PubMed ID: 10396363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum insulin-like growth factor (IGF) binding protein-3 and IGF-I levels during childhood and adolescence. A cross-sectional study.
    Andrade Olivié MA; García-Mayor RV; González Lestón D; Rodríguez Sousa T; Segura Dominguez A; Alvarez-Novoa R; Antelo Cortizas J
    Pediatr Res; 1995 Aug; 38(2):149-55. PubMed ID: 7478808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ovarian expression of insulin-like growth factor-I (IGF-I), IGF binding proteins, and growth hormone (GH) receptor in heifers actively immunized against GH-releasing factors.
    Cohick WS; Armstrong JD; Whitacre MD; Lucy MC; Harvey RW; Campbell RM
    Endocrinology; 1996 May; 137(5):1670-7. PubMed ID: 8612500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circadian variation in serum free ultrafiltrable insulin-like growth factor I concentrations in healthy children.
    Heuck C; Skjaerbaek C; Orskov H; Wolthers OD
    Pediatr Res; 1999 May; 45(5 Pt 1):733-6. PubMed ID: 10231873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overnight levels of luteinizing hormone, follicle-stimulating hormone and growth hormone before and during gonadotropin-releasing hormone analogue treatment in short boys born small for gestational age.
    van der Kaay DC; de Jong FH; Rose SR; Odink RJ; Bakker-van Waarde WM; Sulkers EJ; Hokken-Koelega AC
    Horm Res; 2009; 71(5):260-7. PubMed ID: 19339790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of circulating IGF-I and IGFBP-3 levels by hormonal regulators of energy homeostasis in obese children.
    Woelfle JF; Harz K; Roth C
    Exp Clin Endocrinol Diabetes; 2007 Jan; 115(1):17-23. PubMed ID: 17286229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Normalization of the IGF-IGFBP axis by sustained nightly insulinization in type 1 diabetes.
    Ekström K; Salemyr J; Zachrisson I; Carlsson-Skwirut C; Ortqvist E; Bang P
    Diabetes Care; 2007 Jun; 30(6):1357-63. PubMed ID: 17372150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Somatomedin-C in normal puberty and in true precocious puberty before and after treatment with a potent luteinizing hormone-releasing hormone agonist.
    Harris DA; Van Vliet G; Egli CA; Grumbach MM; Kaplan SL; Styne DM; Vainsel M
    J Clin Endocrinol Metab; 1985 Jul; 61(1):152-9. PubMed ID: 3889035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.